Glutsch, V <br/><br/>
Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  10 2019 
 - 1667-1668 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdz230  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Merkel Cell--drug therapy<br/>Drug Resistance, Neoplasm--drug effects<br/>Humans<br/>Ipilimumab--administration & dosage<br/>Male<br/>Middle Aged<br/>Nivolumab--administration & dosage<br/>Prognosis<br/>Skin Neoplasms--drug therapy